Biostar Pharmaceuticals, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported sales of $6,908,747 against $13,181,164 a year ago. Loss from operations was $889,998 against $763,112 a year ago.

Loss before income taxes was $638,975 against income of $605,911 a year ago. Net loss was $160,104 or $0.01 per basic and diluted share against net income of $306,670 or $0.02 per basic and diluted share a year ago. Net cash provided by operating activities was $2,835,026 against $3,104,261 a year ago.

Purchase of property, plant and equipment was $30,646 against $1,957 a year ago.